AgomAb Therapeutics N.V. American Depositary Shares current ratio

The Current Ratio as of October 2026 (TTM) for AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is 12.88

According to AgomAb Therapeutics N.V. American Depositary Shares’s latest financial reports and current stock price. The company's current Current Ratio is 12.88. This represents a change of -1.76% compared to the average of 13.11 of the last 4 quarters.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Historical Current Ratio (quarterly & annually)

How has AGMB Current Ratio performed in the past?

The mean historical Current Ratio of AgomAb Therapeutics N.V. American Depositary Shares over the last ten years is 1.63. The current 12.88 Current Ratio has changed 689.84% with respect to the historical average. Over the past ten years (40 quarters), AGMB's Current Ratio was at its highest in in the December 2024 quarter at 19.05. The Current Ratio was at its lowest in in the December 2025 quarter at 6.52.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of AgomAb Therapeutics N.V. American Depositary Shares Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Average Current Ratio

How has AGMB Current Ratio performed in the past?

The current Current Ratio of AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) Current Ratio vs. Peers

How is AGMB’s Current Ratio compared to its peers?

AgomAb Therapeutics N.V. American Depositary Shares’s Current Ratio is greater than Odyssey Therapeutics, Inc. (11.36), greater than Alumis Inc. (6.74), less than Equillium, Inc. (23.40), greater than AnaptysBio, Inc. (5.61), greater than Aclaris Therapeutics, Inc. (3.46),

Build a custom stock screener for AgomAb Therapeutics N.V. American Depositary Shares (AGMB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AgomAb Therapeutics N.V. American Depositary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AgomAb Therapeutics N.V. American Depositary Shares (AGMB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AgomAb Therapeutics N.V. American Depositary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.